GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Up 934.4% in March

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 33,100 shares, a growth of 934.4% from the February 28th total of 3,200 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 1,865,900 shares, the days-to-cover ratio is presently 0.0 days.

GlobeStar Therapeutics Price Performance

GSTC stock opened at $0.00 on Friday. GlobeStar Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.00.

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.